Perturbations in MYOCD, are associated with heart failure, acute vessel disease, diabetes and cancer [45], with some MYOCD-related transcription factors regulating cytoskeletal dynamics [46] which can benefit tumour migration and invasion [47]. This evidence concerns the gene MYOCD and neoplasm.